NANETS Regional NET Education: The Multidisciplinary
Management of NET Disease

CME/CE Certified Activity
Saturday, April 13, 2019
7:30am – 4:00pm 


Hilton Baltimore BWI Airport
1739 W. Nursery Road
Linthicum, MD 21090


Jointly Provided by Mercy Medical Center and North American Neuroendocrine Tumor Society.

Course Director

Sandy D. Kotiah, MD, Mercy Medical Center  


Neuroendocrine tumors (NET) are considered to be a rare disease although the frequency of diagnosis has increased over the last ten years. As this is a rare disease, clinicians often do not know how to implement the appropriate care plan and until the last ten years there was great variability in terms of treatment. The diagnosis, treatment and management of NETs are time consuming, complex and require a multidisciplinary approach. Many healthcare providers who face these challenges are not adequately equipped in their knowledge or experience optimally manage NET disease.

The field of NET research has been evolving with new drug approvals and treatment modalities. In addition, experts in the field of NET disease have continued to develop strategies to improve diagnosis, treatment and management of NET cancers. It is through convening professionals in the areas of oncology, gastroenterology, pulmonology, surgery, radiology and allied fields that the awareness and understanding of NET diseases will expand, resulting in better treatment for NET patients.

Target Audience

This activity is designed for oncologists, gastroenterologists, pulmonologists, surgeons, radiologists, pathologists, primary care physicians, advanced practice nurses, nurses, physician assistants, pharmacists, fellows, students, and other allied health professionals involved with or interested in the treatment of patients with neuroendocrine tumors.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Review current concepts of neuroendocrine tumor pathology, molecular profile, classification, and grading
  • Discuss the various diagnostic processes and use of current and emerging diagnostic tools to determine neuroendocrine tumor type
  • Summarize the current safety and efficacy data of the various surgical, medical and loco-regional approaches in the management of neuroendocrine tumors
  • Recognize the clinical features associated with carcinoid syndrome
  • Apply a multidisciplinary approach to the management of patients with neuroendocrine tumors
  • Review clinical trial data and ongoing studies evaluating novel management strategies for the treatment of neuroendocrine tumors


7:30 - 8:00     Registration & Breakfast

8:00 - 8:10     Welcome and Opening Remarks --- Sandy D. Kotiah, MD, Mercy Medical Center 

8:10 - 9:30     Overview of Neuroendocrine Tumors

  • Background, Epidemiology, Symptoms, Biochemical Diagnosis and Pathology of NETs --- Sandy D. Kotiah, MD, Mercy Medical Center
  • Pathology of NETs: General Features, Grade, Staging, Sites --- Laura Tang, MD, PhD, Memorial Sloan Kettering Cancer Center
  • Endoscopic Diagnosis and Management of NETs --- Amit Raina, MD, Mercy Medical Center

9:30 - 10:45   Surgical Treatment of NETs

  • Surgical Principles in SBNETs: Primary, Nodes, Metastases --- Eric Liu, MD, Rocky Mountain Cancer Center
  • Surgical principles in PNETs --- Eric Liu, MD, Rocky Mountain Cancer Center  
  • Surgery for Gastric, Duodenal, and Colorectal NETs --- Vadim Gushchin, MD, Mercy Medical Center 
  • Principles of Hepatic Cytoreduction --- Vadim Gushchin, MD, Mercy Medical Center 
  • Panel: Question and Answer 

10:45 - 11:00 Break

11:00 - 11:30 Hormonal Management of NETs

  • Hormonal syndromes in NETs, functional PNETs --- Sandy Kotiah, MD, Mercy Medical Center 
  • Symptom Control in NETs --- Sandy Kotiah, MD, Mercy Medical Center 

11:30 - 12:15 Medical Management of NETs

  • Overview of Clinical Trials and Agents used in NETs --- Jonathan R. Strosberg, MD, Moffitt Cancer Center and Research Institute 
  • Treatment of Progressive and Poorly-differentiated NETs --- Jonathan R. Strosberg, MD, Moffitt Cancer Center and Research Institute
  • Panel: Question and Answer session for Hormonal and Medical Management --- Sandy Kotiah, MD and Jonathan R. Strosberg, MD

12:15-1:00     Lunch

1:00 - 2:00 pm   Radiology Management of NET

  • Review of Current Imaging Modalities in NET --- Michael Morris, MD, Mercy Medical Center 
  • PRRT in the treatment of NET-- Lilja Solnes, MD, Johns Hopkins University 
  • Imaging Modalities and Interventional Management of NET --- Allen Missoi, MD, Mercy Medical Center 

2:00 - 2:30     Hereditary Syndromes with NETs: MEN1/2, VHL --- Ashley Low, MGS, Mercy Medical Center

2:30 - 3:30     Case Presentations and Multidisciplinary Tumor Board


This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of CMEsolutionsand the North American Neuroendocrine Tumor Society. The CMEsolutions is accredited by the ACCME to provide continuing medical education for physicians

The CMEsolutions designates this live meeting for a maximum of 6.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been submitted to the Continuing Nursing Education Group, for approval to award nursing contact hours. The Continuing Nursing Education Group is accredited as an approver of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Method of Participation

In order to meet the learning objectives and receive continuing education credit for this activity, participants are required to check in at the registration desk, attend the activity, and complete the online evaluation form at the conclusion of the activity. A letter certifying attendance and credit verification will be mailed to participants upon completion of the online evaluation survey.


Online registration available.
In-person registration available onsite on day of program and will be accommodated on a space-available basis

Registration fee:

$65 - MD, PharmD, Doctoral Level 
$35 - Allied Health
Complimentary - Student/Fellow/Resident

$95 - MD, PharmD, Doctoral Level 
$50 - Allied Health
Complimentary - Student/Fellow/Resident

Cancellation Policy: A full refund will be made if registration is canceled, in writing, on or before April 7, 2019. On or after April 7 2019, no refund will be made.

Mercy Medical Center and North American Neuroendocrine Tumor Society reserve the right to modify the activity content, faculty, and activities and reserve the right to cancel this activity if necessary. If the program is cancelled, liability is limited to the registration fee.


Please contact us with any questions.